MeNow
AI Platform for Discovering and Evaluating Natural Bioactive Ingredients for Cosmetics and Food
Company Overview
Snapshot
Founded in July 2022 by Hilla Ben-Hamo and Coralie Ebert, MeNow operates with 11–50 employees. The company is currently in a Pre-Funding stage, focusing on the AI-driven discovery of natural bioactive compounds. In January 2023, MeNow announced a collaboration with Green Mountain Biotech for the AI-based development of skincare products.
Business overview
MeNow is an AI-driven discovery company specializing in the development of novel natural bioactive compounds for the food, cosmetics, and health industries. The company leverages advanced probabilistic AI, systems biology, and molecular science to identify and validate new bioactives with strong efficacy, safety, and scalability. MeNow has generated proprietary intellectual property around key longevity-relevant pathways, including SIRT1 activation, heparanase modulation, and GLP-1–associated mechanisms, with applications spanning metabolic health, inflammation, tissue function, and healthspan support. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology, Drugs Discovery & Development, and Cosmetic Materials.
Strategic signal
In January 2023, MeNow announced a strategic collaboration with Green Mountain Biotech to develop AI-based skincare products derived from Traditional Chinese Medicine. This partnership signals MeNow's ability to translate its AI-driven discovery platform into practical applications within the cosmetics industry, validating its technology for identifying effective natural ingredients and expanding its market reach through strategic alliances.
Log in to access full profile ›Company Intelligence Q&A
- When was MeNow founded and by whom?
- MeNow was founded in July 2022 by Co-founders Hilla Ben-Hamo and Coralie Ebert.
- What is MeNow's primary focus?
- MeNow is an AI-driven discovery company focused on developing novel natural bioactive compounds for the food, cosmetics, and health industries.
- What significant collaboration did MeNow announce in early 2023?
- In January 2023, MeNow announced a collaboration with Green Mountain Biotech for the AI-based development of skincare products based on Traditional Chinese Medicine.
- What technology does MeNow utilize in its discovery process?
- MeNow integrates advanced probabilistic AI, systems biology, and molecular science to identify and validate new bioactives.
- What intellectual property has MeNow generated?
- MeNow has generated proprietary intellectual property around longevity-relevant biology, specifically focusing on SIRT1 activation, heparanase modulation, and GLP-1–associated mechanisms.